Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HR17031 vs Components in T2D Inadequately Controlled on Metformin
NCT05333835Phase 2Unknown
- Sponsor
- Hengrui
- Start
- Jul 2022
- Primary completion
- Mar 2024
- Modality
- Peptides, Insulin and Analogs
- Countries
- 1
01
Overview
A Phase 2 trial of insulin sudelidec, noiiglutide in type 2 diabetes mellitus (T2DM), sponsored by Hengrui. Status: unknown.
02
Drugs
insulin sudelidecnoiiglutide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT05333835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05333835.